advertisement
07 August 2013

Mead Johnson settles over baby formula probe

Mead Johnson Nutrition said it will pay a penalty of about $33 million related to a probe by China into anti-competitive behaviour.

0

Mead Johnson Nutrition Co on Tuesday said it will pay a penalty of about $33 million related to a probe by China into anti-competitive behaviour by baby formula makers.

The maker of Enfamil formula said the payment will reduce its full-year earnings by about 12 cents per share. But it reiterated its 2013 earnings forecast for profit, excluding one-time items, of $3.22 (±R32.20) to $3.30 (±R33.00) per share.

Mead Johnson, along with Danone, Nestle, Abbott Laboratories and Hong Kong-listed Biostime International Holdings said in recent weeks that they were being investigated by China's National Development and Reform Commission, an economic planning agency, for possible antitrust violations, including price-fixing.

As a result, Mead Johnson and others cut prices on their baby formulas.

Foreign infant formula is highly coveted in China since public trust was damaged by a 2008 tainted infant formula scandal that left at least six children dead. Foreign brands now account for about half of total sales.

 
NEXT ON HEALTH24X
advertisement

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Live healthier

Watch out! »

Gross fungal infections you can pick up at the gym

You go to gym to exercise. But make sure the only thing you pick up is a dumbbell and not one of these gross fungal infections.

Holiday health »

Your 10-step asthma holiday checklist

Don’t let asthma ruin your summer holiday. Whether you are travelling or embracing the summer at home, make sure you plan ahead.